SARS-COV-2
Clinical trials for SARS-COV-2 explained in plain language.
Never miss a new study
Get alerted when new SARS-COV-2 trials appear
Sign up with your email to follow new studies for SARS-COV-2, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA vaccines aim to shield healthy 50-64 year olds from COVID-19
⭐️ VACCINE ⭐️ OngoingThis study tests two updated mRNA COVID-19 vaccines (mRNA-1283 and a variant version of mRNA-1273) in 30,000 healthy adults aged 50 to 64 who are not at high risk for severe COVID-19. The goal is to see if these vaccines can prevent symptomatic COVID-19 compared to a placebo. Res…
Matched conditions: SARS-COV-2
Phase: PHASE4 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 20, 2026 11:57 UTC
-
COVID-19 drug trial halted before it began
Disease control TerminatedThis study was designed to see if an inhaled medication called ZYESAMI could help people with severe COVID-19 avoid needing a breathing machine. The trial was planned for adults with low oxygen levels or rapid breathing, but it was withdrawn before any participants enrolled. No r…
Matched conditions: SARS-COV-2
Phase: PHASE3 • Sponsor: APR Applied Pharma Research s.a. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Real-world data to reveal vaccine power against long COVID
Knowledge-focused OngoingThis study uses anonymous health records from California and Louisiana to see how effective the Pfizer-BioNTech COVID-19 vaccine is at preventing post-COVID conditions (long COVID). Researchers will also look at who gets vaccinated. The study includes adults with a COVID-19 diagn…
Matched conditions: SARS-COV-2
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 26, 2026 05:40 UTC
-
Heart scans after COVID shots: what researchers are finding
Knowledge-focused OngoingThis study uses heart scans and blood tests to understand why some people develop heart inflammation after COVID-19 vaccination. Researchers are comparing people with and without symptoms to find early warning signs. The goal is to identify those at risk and determine if long-ter…
Matched conditions: SARS-COV-2
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Knowledge-focused
Last updated May 26, 2026 05:29 UTC
-
COVID-19 safety study withdrawn before any participants enrolled
Knowledge-focused TerminatedThis study was designed to check the safety of SARS-CoV-2 for treating COVID-19, but it was withdrawn before anyone joined. The plan was to measure things like humidity, heavy metals, and germs in the treatment. No results are available because no one took part.
Matched conditions: SARS-COV-2
Phase: PHASE2 • Sponsor: DHA Coffee Co., Ltd • Aim: Knowledge-focused
Last updated May 26, 2026 05:29 UTC
-
Thousands tracked to see if moderna vaccines are safe over time
Knowledge-focused OngoingThis study watches over 4,200 people in South Korea who received Moderna's COVID-19 vaccines to see if any side effects happen over time. It does not test a new treatment or vaccine, but simply collects safety information during routine care. Participants are adults and teens age…
Matched conditions: SARS-COV-2
Sponsor: ModernaTX, Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Hospital staff antibody study reveals vaccine response over a year
Knowledge-focused OngoingThis study looks at how well the AstraZeneca COVID-19 vaccine works in 200 hospital employees. Researchers measure antibody levels in the blood at 6 weeks, 6 months, and 12 months after vaccination. The goal is to understand how long the immune protection lasts and how many peopl…
Matched conditions: SARS-COV-2
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Knowledge-focused
Last updated May 19, 2026 12:01 UTC
-
Study on quarantine's mental toll on psychiatric patients pulled before it began
Knowledge-focused TerminatedThis study planned to check how the COVID-19 quarantine affected the mental health of people already being treated by a psychiatrist. Researchers wanted to measure symptoms of post-traumatic stress disorder (PTSD) and other mental health issues during quarantine and a few months …
Matched conditions: SARS-COV-2
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
12,000 koreans monitored for vaccine side effects over 6 years
Knowledge-focused OngoingThis study is tracking the safety of the BNT162b2 COVID-19 vaccine (including the bivalent version) in 12,000 people in Korea who received the vaccine as part of routine care. Researchers are collecting information on side effects that happen within a week and up to 28 days after…
Matched conditions: SARS-COV-2
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 01, 2026 15:58 UTC